Danaher Co. (DHR) Stake Lessened by BRYN MAWR TRUST Co
BRYN MAWR TRUST Co decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 23.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,498 shares of the conglomerate’s stock after selling 1,702 shares during the period. BRYN MAWR TRUST Co’s holdings in Danaher were worth $511,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. Zions Bancorporation raised its stake in Danaher by 118.3% in the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after purchasing an additional 667 shares during the last quarter. Patten Group Inc. raised its stake in Danaher by 262.3% in the 3rd quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 3,497 shares during the last quarter. First Personal Financial Services raised its stake in Danaher by 128.9% in the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 691 shares during the last quarter. Calton & Associates Inc. acquired a new position in Danaher in the 4th quarter valued at $114,000. Finally, Truewealth LLC acquired a new position in Danaher in the 4th quarter valued at $121,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DHR has been the subject of several recent research reports. Stifel Nicolaus increased their price objective on Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and issued a $110.00 target price on shares of Danaher in a research note on Tuesday, January 30th. UBS began coverage on Danaher in a research note on Monday, January 22nd. They issued a “buy” rating and a $99.97 target price for the company. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Finally, Citigroup raised their target price on Danaher to $107.00 and gave the stock a “buy” rating in a research note on Friday, December 15th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. Danaher has a consensus rating of “Buy” and a consensus price target of $102.23.
Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The business had revenue of $5.09 billion during the quarter, compared to analysts’ expectations of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company’s revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.05 EPS. research analysts predict that Danaher Co. will post 4.38 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Thursday, March 29th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.66%. Danaher’s dividend payout ratio is currently 15.86%.
In other news, EVP William K. Daniel sold 131,066 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the completion of the transaction, the executive vice president now directly owns 270,523 shares in the company, valued at approximately $27,606,872.15. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Rainer Blair sold 3,981 shares of the stock in a transaction on Monday, February 26th. The stock was sold at an average price of $100.05, for a total value of $398,299.05. Following the transaction, the insider now owns 49,751 shares of the company’s stock, valued at $4,977,587.55. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 313,260 shares of company stock valued at $31,657,786. Company insiders own 12.20% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.watchlistnews.com/danaher-co-dhr-stake-lessened-by-bryn-mawr-trust-co/1959108.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.